Full video transcriptClick to expand
Auto-generated transcript of @liftsbyfahd's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Alright boys, today is day one on MK67.
- 0:05I don't know if you can say it on TikTok or not,
- 0:06and I'm not trying to get banned
- 0:07and go through the whole issue.
- 0:08Anyways, that's besides the point.
- 0:10I'm gonna be documenting my journey.
- 0:12I'm only gonna run a four week cycle.
- 0:13I'm gonna see how it plays out.
- 0:15I'm most looking forward to like,
- 0:17just the recovery and like the sleep.
- 0:20I'm not really looking forward to the water retention
- 0:22and like how that kind of plays out.
- 0:23Like I'm really not a fan of being bloated.
- 0:25But yeah, I'm only doing a short cycle.
- 0:27Four weeks, 15 milligrams.
- 0:29The thing is like right now,
- 0:30I'm training around six, seven days a week.
- 0:32We're gonna see how it improves recovery.
- 0:34We're gonna see if it affects the appetite.
- 0:37Scared about the appetite?
- 0:37Like I already eat a lot.
- 0:39And I don't know that's kind of scary.
- 0:41But point is that I guess we're no longer
- 0:44gonna be naddy as of today.
- 0:46I'm gonna take it at night.
- 0:47I heard that kind of helps with the appetite.
- 0:49That way you're not as hungry.
- 0:50If you take it in the morning,
- 0:51you'll be super hungry throughout the day.
- 0:53So I mean, if I take it during the night,
- 0:56it'll help to sleep.
- 0:57Cause it like girl comorant and stuff
- 0:59and like that promotes deep sleep.
- 1:00And then in the morning,
- 1:02I hopefully don't wake up super hungry.
- 1:04But if I do, we'll deal with it.
- 1:05See how that plays out.
- 1:07Anyways, I'm gonna be documenting it every single day.
- 1:09So I guess follow along.
- 1:12I'll post something new.
- 1:13Like some new updates on how I'm feeling,
- 1:15how it's playing out,
- 1:16how the body's feeling, how the recovery's going.
- 1:18Every single day.
- 1:19So follow along.
- 1:20Let's see how it goes.
MK-677 for muscle gains: what the evidence actually shows
Quick answer
MK-677 (ibutamoren) is an orally bioavailable ghrelin receptor agonist that stimulates GH and IGF-1 secretion. Clinical studies have documented improvements in REM sleep architecture and appetite stimulation as primary pharmacodynamic effects. Chronic use raises IGF-1, which warrants baseline and follow-up lab monitoring, particularly for fasting glucose and insulin sensitivity, neither of which this creator discusses.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For MK-677 for muscle gains: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis
Used for PCOS pages comparing metabolic and weight-management approaches.
PubMed
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity
Supports PCOS, obesity, and hormonal-regulation context.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
MK-677 for muscle gains: what the evidence actually shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "MK-677 for muscle gains: what the evidence actually shows" from liftsbyfahd. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: MK-677 (ibutamoren) is an orally bioavailable ghrelin receptor agonist that stimulates GH and IGF-1 secretion.
The reason this review is not generic is the source wording and the canonical claim label "peptides day 1 boys lets run it up gym fitness viral mk677 gymtok." In this clip, the useful excerpt is: "Alright boys, today is day one on MK67." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Ipamorelin, the first selective growth hormone secretagogue (1998), The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation (2001), and Influence of chronic treatment with the growth hormone secretagogue Ipamorelin (2002), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
MK-677 (ibutamoren) is an orally bioavailable ghrelin receptor agonist that stimulates GH and IGF-1 secretion.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- MK-677 (ibutamoren) is an orally bioavailable ghrelin receptor agonist that stimulates GH and IGF-1 secretion. Clinical studies have documented improvements in REM sleep architecture and appetite stimulation as primary pharmacodynamic effects. Chronic use raises IGF-1, which warrants baseline and follow-up lab monitoring, particularly for fasting glucose and insulin sensitivity, neither of which this creator discusses.
- Copinschi et al. (1997) found MK-677 increased REM sleep duration in controlled trials, so the sleep rationale is not without basis.
- MK-677 activates ghrelin receptors, and ghrelin is the primary hunger-stimulating hormone. Appetite increase is one of its most consistent documented effects.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Copinschi et al. (1997) found MK-677 increased REM sleep duration in controlled trials, so the sleep rationale is not without basis.
- MK-677 activates ghrelin receptors, and ghrelin is the primary hunger-stimulating hormone. Appetite increase is one of its most consistent documented effects.
- Nass et al. (2008) reported edema and insulin resistance signals in a two-year MK-677 trial. The creator mentions bloating but never addresses blood glucose.
- Night dosing to reduce daytime hunger is a common user strategy with no controlled evidence behind it. It shifts when hunger peaks, not necessarily total caloric drive.
- MK-677 is not FDA-approved and cannot be legally sold as a supplement. Legitimate access in the U.S. requires a licensed provider and a prescription through regulated compounding channels.
- IGF-1 elevation from MK-677 is measurable within days, not weeks. A four-week run without baseline labs is not a low-stakes experiment.
- Self-sourcing gray-market compounds introduces contamination and dosing accuracy risks that are entirely absent from this video's framing.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @liftsbyfahd actually say?
The creator is starting a four-week, 15 mg daily cycle of MK-677 and plans to document it. His main hopes are better recovery and deeper sleep. His main worries are water retention and a bigger appetite. He says he's taking it at night because it will "help to sleep" and reduce daytime hunger. He also mentions "no longer being natty" as of today.
A few things stand out immediately. He mispronounces it as "MK67" and references "girl comorant," which appears to be a mangled attempt at saying "ghrelin" or possibly a reference to growth hormone release. These aren't just verbal slips. They suggest a limited understanding of the mechanism he's experimenting with. That matters when you're talking about a compound that affects your endocrine system.
Does the science back this up?
On sleep and recovery, he's actually closer to correct than most MK-677 influencers. That's worth acknowledging. MK-677 (ibutamoren) is a ghrelin receptor agonist and growth hormone secretagogue. It raises GH and IGF-1 levels by mimicking ghrelin. On the sleep side, Copinschi et al. (1997, American Journal of Physiology) found that MK-677 increased REM sleep duration and sleep quality in healthy older adults. More recently, Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed increases in GH pulse amplitude with oral dosing.
On appetite, the science is straightforward and the creator is right to be nervous. Ghrelin is the hunger hormone. Activating its receptor reliably increases appetite in clinical settings. van der Lely et al. (2004, Endocrine Reviews) documented significant appetite stimulation as one of the most consistent effects of ghrelin-pathway activation. Taking it at night to blunt daytime hunger is a common user strategy, but there's no controlled evidence that timing meaningfully reduces total caloric drive versus simply shifting when it peaks.
What did they get wrong (or right)?
Right: The sleep improvement rationale is scientifically grounded. The appetite concern is well-founded and honest. The water retention worry is also accurate. MK-677 increases aldosterone-like fluid retention in some users, and this is documented in clinical trials, not just gym lore.
Wrong: The "girl comorant" reference is almost certainly a garbled attempt at describing ghrelin or growth hormone-releasing hormone, neither of which he explains correctly. More importantly, he frames this as a simple four-week experiment with no mention of baseline bloodwork, no mention of monitoring IGF-1 levels, and no mention of a prescribing provider. MK-677 chronically elevates IGF-1. Hartman et al. (2001, Journal of Clinical Endocrinology and Metabolism) noted that sustained IGF-1 elevation raises questions about long-term safety signals including insulin resistance, which he doesn't address at all. His blood sugar isn't discussed once. That's a gap.
Also worth flagging: calling a four-week run a "short cycle" undersells the fact that MK-677's half-life means you can hit steady-state IGF-1 elevation within days. Four weeks is not trivial from an endocrine standpoint.
What should you actually know?
MK-677 is not a SARM, though it's often sold alongside them. It is an orally active ghrelin receptor agonist. It is not FDA-approved for any indication. It is not legal to sell as a dietary supplement in the U.S. It is available through some compounding pharmacies under physician oversight for specific clinical applications, but self-sourcing from the gray market, which is what this video implies, comes with real quality control risks.
The sleep and recovery benefits the creator is chasing are real enough in the literature to take seriously. But the studies showing those benefits were conducted in controlled settings with verified compounds, baseline bloodwork, and medical supervision. Training six to seven days a week and layering in a compound that elevates IGF-1 and affects insulin sensitivity without any metabolic monitoring is a risk that doesn't appear anywhere in this video.
If you're genuinely interested in whether MK-677 could be appropriate for your recovery goals, that conversation belongs with a licensed provider who can look at your actual labs, not a TikTok day-one vlog.
Bottom line on the claims
The creator gets partial credit for identifying real effects of MK-677: sleep quality improvement and appetite stimulation are documented. The night-dosing strategy is plausible but unproven in controlled trials. What's missing is everything about safety monitoring, IGF-1 tracking, blood glucose, sourcing quality, and the fact that in most jurisdictions you need a prescription to obtain this compound legally through regulated channels. Enthusiasm is not a substitute for a baseline metabolic panel.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
liftsbyfahd · TikTok creator
22.8K views on this video
DAY 1 BOYS LETS RUN IT UP #gym #fitness #viral #mk677 #gymtok
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about copinschi et al. (1997) found mk-677 increased rem sleep duration?
Copinschi et al. (1997) found MK-677 increased REM sleep duration in controlled trials, so the sleep rationale is not without basis.
What does the video say about mk-677 activates ghrelin receptors,?
MK-677 activates ghrelin receptors, and ghrelin is the primary hunger-stimulating hormone. Appetite increase is one of its most consistent documented effects.
What does the video say about nass et al. (2008) reported edema?
Nass et al. (2008) reported edema and insulin resistance signals in a two-year MK-677 trial. The creator mentions bloating but never addresses blood glucose.
What does the video say about night dosing to reduce daytime hunger?
Night dosing to reduce daytime hunger is a common user strategy with no controlled evidence behind it. It shifts when hunger peaks, not necessarily total caloric drive.
What does the video say about mk-677?
MK-677 is not FDA-approved and cannot be legally sold as a supplement. Legitimate access in the U.S. requires a licensed provider and a prescription through regulated compounding channels.
What does the video say about igf-1 elevation from mk-677?
IGF-1 elevation from MK-677 is measurable within days, not weeks. A four-week run without baseline labs is not a low-stakes experiment.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by liftsbyfahd, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.